We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Search results
From Proteopedia
You searched for Kozisek,_M.
There is no page with the exact title "Kozisek,_M.". The search results for "Kozisek,_M." are displayed below. You can create a page titled Kozisek,_M. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Kozisek M (40 bytes)
1: List of pages with the keyword Kozisek M - Category:Kozisek, M (41 bytes)
1: List of pages with the keyword Kozisek, M
Page text matches
- 1ztz (11,666 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... and potent inhibitors of HIV protease.,Cigler P, Kozisek M, Rezacova P, Brynda J, Otwinowski Z, Pokorna J,...
44: [[Category: Kozisek M]] - 2hkf (5,392 bytes)
5: ...mo sapiens] and [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic infor...
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
25: ...der P, Collard R, Fabry M, Horejsi M, Rezacova P, Kozisek M, Zavada J, Sedlacek J, Rulisek L, Brynda J Prot... - 2hkh (5,157 bytes)
5: ...h sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic infor...
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
24: ...der P, Collard R, Fabry M, Horejsi M, Rezacova P, Kozisek M, Zavada J, Sedlacek J, Rulisek L, Brynda J Prot... - 9qtb (4,576 bytes)
5: ...ia.org/wiki/Rift_valley_fever_virus_(STRAIN_ZH-548_M12) Rift valley fever virus (STRAIN ZH-548 M12)]. ...
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
15: ...va A, Liscakova V, Hodek J, Konvalinka J, Demo G, Kozisek M ACS Infect Dis. 2025 Oct 30. doi: 10.1021/acsin...
31: [[Category: Kozisek M]] - 2pyn (11,557 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2pym (11,556 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2q64 (11,556 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2q63 (11,556 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2qak (9,109 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
28: [[Category: Kozisek M]] - 2qhc (4,903 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... to HIV protease inhibitor lopinavir.,Saskova KG, Kozisek M, Lepsik M, Brynda J, Rezacova P, Vaclavikova J,...
39: [[Category: Kozisek M]] - 2rkf (4,983 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...tease mutants with insertions in the flap region.,Kozisek M, Saskova KG, Rezacova P, Brynda J, van Maarseve...
39: [[Category: Kozisek M]] - 2rkg (4,929 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...tease mutants with insertions in the flap region.,Kozisek M, Saskova KG, Rezacova P, Brynda J, van Maarseve...
39: [[Category: Kozisek M]] - 2z54 (11,531 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... to HIV protease inhibitor lopinavir.,Saskova KG, Kozisek M, Lepsik M, Brynda J, Rezacova P, Vaclavikova J,...
42: [[Category: Kozisek M]] - 3ggu (11,313 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... to the protease inhibitor darunavir.,Saskova KG, Kozisek M, Rezacova P, Brynda J, Yashina T, Kagan RM, Kon... - 3i8w (10,627 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...tallacarboranes.,Rezacova P, Pokorna J, Brynda J, Kozisek M, Cigler P, Lepsik M, Fanfrlik J, Rezac J, Grant... - 3t11 (8,568 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
21: [[Category: Kozisek M]] - 3t3c (11,006 bytes)
17: ...iral fitness caused by a highly mutated protease.,Kozisek M, Henke S, Saskova KG, Jacobs GB, Schuch A, Buch...
33: [[Category: Kozisek, M]] - 3ttp (10,569 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ... heavily mutated patient-derived HIV-1 proteases.,Kozisek M, Lepsik M, Grantz Saskova K, Brynda J, Konvalin...
31: [[Category: Kozisek M]] - 3u7s (8,675 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
21: [[Category: Kozisek M]] - 3bxh (5,227 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... of several glycolytic intermediates.,Rezacova P, Kozisek M, Moy SF, Sieglova I, Joachimiak A, Machius M, O...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
